Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

By R. Hotchkiss, Guillaume Monneret, D. Payen. Nature reviews. Immunology, 2013

2,432 citations recorded by the source corpus.

Sepsis — which is a severe life-threatening infection with organ dysfunction — initiates a complex interplay of host pro-inflammatory and anti-inflammatory processes. Sepsis can be considered a race to the death between the pathogens and the host immune system, and it is the proper balance between the often competing pro- and anti-inflammatory pathways that determines the fate of the individual. Although the field of sepsis research has witnessed the failure of many highly touted clinical trials, a better understanding of the pathophysiological basis of the disorder and the mechanisms responsible for the associated pro- and anti-inflammatory responses provides a novel approach for treating this highly lethal condition. Biomarker-guided immunotherapy that is administered to patients at the proper immune phase of sepsis is potentially a major advance in the treatment of sepsis and in the field of infectious disease.

Subfields: Epidemiology, Immunology, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/535b719c0a9114acd54c6d38be1a88c7941aa466

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

  1. Derek C. Angus
  2. Min Huang
  3. S. Maggini
  4. H. Prescott
  5. A. Carr
  6. Jingqian Su
  7. Shaoli Cai

In Immunology

  1. Derek C. Angus
  2. Min Huang
  3. S. Maggini
  4. H. Prescott
  5. A. Carr
  6. Jingqian Su
  7. Shaoli Cai

In Nutrition and Dietetics

  1. S. Maggini
  2. Derek C. Angus
  3. Min Huang
  4. H. Prescott
  5. Jingqian Su
  6. Shaoli Cai

Citations in the corpus